Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| My Size, Inc.MYSZ · Entity 8556 | Former CTO | September 06, 2023 | September 13, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
My Size, Inc.
Report date September 06, 2023 · Filed September 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,776 |
Reported balance
After 2023-09-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-09-06 · Sale · Disposed 1,211 · Balance 12,776 F1: In recognition of his service to the issuer, the Reporting Person's non-vested restricted stock awards were accelerated effective July 31, 2023, immediately prior to the effectiveness of his departure from the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: In recognition of his service to the issuer, the Reporting Person's non-vested restricted stock awards were accelerated effective July 31, 2023, immediately prior to the effectiveness of his departure from the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2023 Filed Sep 13, 2023 20:15 UTC | My Size, Inc. MYSZ · Entity 8556 | SaleCommon Stock | 1,211 | $1.41 | $1,707.51 |
DisclosureSEC source: 0001493152-23-032483 · ownership.xml · nonDerivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Former CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,776 F1 · balance_after: In recognition of his service to the issuer, the Reporting Person's non-vested restricted stock awards were accelerated effective July 31, 2023, immediately prior to the effectiveness of his departure from the Company. Read SEC document |
| August 24, 2023 Filed Aug 31, 2023 20:15 UTC | My Size, Inc. MYSZ · Entity 8556 | SaleCommon Stock | 2,013 | $2.47 | $4,972.11 |
DisclosureSEC source: 0001493152-23-031054 · ownership.xml · nonDerivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Former CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,987 F1 · balance_after: In recognition of his service to the issuer, the Reporting Person's non-vested restricted stock awards were accelerated effective July 31, 2023, immediately prior to the effectiveness of his departure from the Company. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 20:33 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027444 · ownership.xml · nonDerivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2023, January 1, 2024 and January 1, 2025, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:34 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 55,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001213900-20-021634 · ownership.xml · derivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock, $.001 par value per share · 55,000 shares Expires 2025-08-10 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. The option vests and becomes exercisable as to one-quarter of the total shares on each of November 26, 2020, May 26, 2021, November 26, 2021, and May 26, 2022. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 22:00 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 2,667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014436 · ownership.xml · derivative · entry 4 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,667 Underlying: Common Stock, $.001 par value per share · 2,667 shares Expires 2024-09-06 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the option granted to the reporting person on April 15, 2019 having a lower exercise price of $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F3 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on July 1, 2019, one third of the total shares vests on July 1, 2020 and the remaining one third of the total shares vests on July 1, 2021. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 22:00 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 2,667 | Not disclosed Strike: $13.65 | Not disclosed |
DisclosureSEC source: 0001213900-20-014436 · ownership.xml · derivative · entry 3 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 2,667 shares Expires 2023-09-06 F4 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the option granted to the reporting person on April 15, 2019 having a lower exercise price of $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged. F3 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on July 1, 2019, one third of the total shares vests on July 1, 2020 and the remaining one third of the total shares vests on July 1, 2021. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 22:00 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 1,004 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014436 · ownership.xml · derivative · entry 2 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004 Underlying: Common Stock, $.001 par value per share · 1,004 shares Expires 2025-05-29 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 22:00 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,004 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014436 · ownership.xml · derivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,004 shares Expires 2024-05-29 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| May 30, 2019 Filed Jun 27, 2019 21:21 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 15,050 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-011677 · ownership.xml · derivative · entry 1 Turchinsky Ilia · CIK 0001774527 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,050 Underlying: Common Stock, $.001 par value per share · 15,050 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.